BIOMARKER:

AR-V7 positive

News alerts, weekly reports and conference planners

AR-V7 positive	Renal Cell Carcinoma	AR-V7 positive	Renal Cell Carcinoma	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
AR-V7 positive	Prostate Cancer	AR-V7 positive	Prostate Cancer	cabazitaxel Sensitive: C3 – Early Trials cabazitaxel Sensitive : C3	cabazitaxel Sensitive: C3 – Early Trials cabazitaxel Sensitive : C3
AR-V7 positive	Prostate Cancer	AR-V7 positive	Prostate Cancer	docetaxel Sensitive: C3 – Early Trials docetaxel Sensitive : C3	docetaxel Sensitive: C3 – Early Trials docetaxel Sensitive : C3
AR-V7 positive	Prostate Cancer	AR-V7 positive	Prostate Cancer	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3	abiraterone acetate Resistant: C3 – Early Trials abiraterone acetate Resistant : C3
AR-V7 positive	Prostate Cancer	AR-V7 positive	Prostate Cancer	enzalutamide capsule Resistant: C3 – Early Trials enzalutamide capsule Resistant : C3	enzalutamide capsule Resistant: C3 – Early Trials enzalutamide capsule Resistant : C3

Associations